Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Antispasmodic Agents. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111170847B reveals a cyanide-free route for Drotaverine intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain safety.